
Castle Biosciences (NASDAQ:CSTL) brought in sales totaling $26.85 million during Q1 according to data provided by Benzinga Pro. However, earnings decreased 282.94%, resulting in a loss of $24.62 million. In Q4, Castle Biosciences brought in $25.04 million in sales but lost $6.43 million in earnings.